435 related articles for article (PubMed ID: 21112656)
21. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.
Ju MJ; Qiu SJ; Fan J; Xiao YS; Gao Q; Zhou J; Li YW; Tang ZY
Am J Clin Pathol; 2009 Apr; 131(4):498-510. PubMed ID: 19289585
[TBL] [Abstract][Full Text] [Related]
22. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
24. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
25. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
26. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
27. [High expression of thrombin receptor PAR1 in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma in early stage].
Zhang XF; Dong QZ; Xue YH; Zhou HJ; Ye QH; Ren N; Jia HL; Qin LX
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):266-70. PubMed ID: 21586224
[TBL] [Abstract][Full Text] [Related]
28. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer.
Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R
Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699
[TBL] [Abstract][Full Text] [Related]
30. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.
Cai XY; Wang JX; Yi Y; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Asian Pac J Cancer Prev; 2014; 15(2):775-80. PubMed ID: 24568494
[TBL] [Abstract][Full Text] [Related]
31. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
[TBL] [Abstract][Full Text] [Related]
32. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
33. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
34. Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection.
Minata M; Kudo M; Harada KH; Ikai I; Nishida N
Oncology; 2013; 84 Suppl 1():88-92. PubMed ID: 23428865
[TBL] [Abstract][Full Text] [Related]
35. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract][Full Text] [Related]
36. Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation.
Sha QQ; Wei QZ; Zhu JK; Wang KX; Wang C; Liu HT; Yu WB; Li MX; Zhang GY
Chin Med J (Engl); 2012 Aug; 125(16):2841-5. PubMed ID: 22932077
[TBL] [Abstract][Full Text] [Related]
37. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection.
Wang X; Ren H; Zhao T; Chen J; Sun W; Sun Y; Ma W; Wang J; Gao C; Gao S; Lang M; Jia L; Hao J
Carcinogenesis; 2014 Oct; 35(10):2283-90. PubMed ID: 25086759
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
40. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
